Tagged with Griffith Institute for Drug Discovery (GRIDD)

Paving the way for personalised medicine, Griffith University researchers will use stem cells from nasal biopsies of people with schizophrenia to discover potential new therapies for this debilitating disease. Schizophrenia is a life-long condition first diagnosed in early adulthood, costing the Australian government about $1.44 billion and the general community $2.25 billion annually. The few […]

A bacterium commonly present in the nose can sneak into the brain and may increase the risk of Alzheimer’s disease. 

A new method of identifying molecular targets to fight disease could help accelerate future drug development new Griffith University research has found.

Scientists at Griffith University are moving towards animal trials in testing a vaccine candidate for COVID-19

World-leading Griffith research into the development of a cell-based therapy for treating spinal cord injuries has received a $5.7m boost from the state government.

Researcher plays key role in discovery of new drug target for stopping the spread of malaria.

Professor Kathy Andrews will launch the latest in a series of books designed to inspire the next generation of female science stars.